
Niccolò Allievi
@allieviniccolo
Surgeon @hpg23bg - Special interest in Peritoneal Surface Malignancy and Colorectal Surgery -
Former Fellow @BasingstokePmi -
Basketball lover 🏀
Daydreamer 🕶️
ID: 1327740976589385738
14-11-2020 22:31:53
83 Tweet
68 Followers
300 Following


We are funding AI research PMI Basingstoke. Predicting PMP disease recurrence & survival, improve patient care & refine primary treatment protocols. Tim Brill, PS Trustee, surgeon Mr Mark Vasanth, Dr Sophia Stanford, Lead Research Scientist #pseudomyxomasurvivor #appendixcancer


Sam Atallah, MD SAGES is in Tampa in 2026! ASCRS_1 Steven D Wexner MD, PhD Mark Soliman, MD, MBA Antonio Caycedo-Marulanda MD, MSc. Antonio de Lacy Neil Smart National Comprehensive Cancer Network (NCCN) Amir Bastawrous, MD, MBA, FACS, FASCRS You can put that same cancer anywhere in the rectum, and as long as the margins are negative and the mesorectum complete, I'm 100% against postop radiation.


Classic and Visceral-Sparing Complete Pelvic Peritonectomy for Peritoneal Surface Malignancies: A Video Demonstrati… pubmed.ncbi.nlm.nih.gov/39388019/ Excellent video article emanating from an European Society of Surgical Oncology (ESSO) webinar on cytoreductive surgery technique. Clear and easy to follow. Lana Bijelic

This new Nature Reviews Cancer article covers state of field in #appendicealcancer & defines the 1st research framework [below]—set to revolutionise the rare #cancer space. Honored to chair Appendix Cancer PMP Research Foundation SA Board & Think Tank behind the effort! OncoAlert 📃 rdcu.be/eaGkv
![Andreana N. Holowatyj 🇺🇦 (@drholowatyj) on Twitter photo This new <a href="/NatureRevCancer/">Nature Reviews Cancer</a> article covers state of field in #appendicealcancer & defines the 1st research framework [below]—set to revolutionise the rare #cancer space. Honored to chair <a href="/acpmpresearch/">Appendix Cancer PMP Research Foundation</a> SA Board & Think Tank behind the effort! <a href="/OncoAlert/">OncoAlert</a>
📃 rdcu.be/eaGkv This new <a href="/NatureRevCancer/">Nature Reviews Cancer</a> article covers state of field in #appendicealcancer & defines the 1st research framework [below]—set to revolutionise the rare #cancer space. Honored to chair <a href="/acpmpresearch/">Appendix Cancer PMP Research Foundation</a> SA Board & Think Tank behind the effort! <a href="/OncoAlert/">OncoAlert</a>
📃 rdcu.be/eaGkv](https://pbs.twimg.com/media/GkQde0abIAA0UsU.jpg)

#AudioVisualAbstract : Characterizing the Immune Environment in #PeritonealCarcinomatosis : Insights for Novel #Immunotherapy Strategies David L. Bartlett, MD Neda Dadgar Christian X. Cruz Pico MD, FACS Casey J Allen, MD rdcu.be/eelDQ Lindsay Friedman, MD, MS Syed A. Ahmad

Risk of lymph node metastases and conditional survival in appendiceal ... sciencedirect.com/science/articl… excellent SURGERY Journal study from Alex Troester Lauren Weaver Julia Frebault Niccolò Allievi Wolfgang Gaertner Paolo Goffredo, MD UMN Surgery

Great Lapco Train the Trainer course at Pelican Cancer Foundation Basingstoke. Training the next generation of trainers with an incredible faculty! Mark Coleman FRCS MD Tom Cecil Thanks to our amazing delegates! Amy Lord Sree Mallappa Mootaz Elhusseini Youssef & others



Fully covered metal stents for post surgical strictures ✅ 💯 % success rate ✅ allowed 💯 % ostomy ✂️takedown ✅ No recurrent strictures Check out study JOGS Stuart K. Amateau, MD PhD Nabeel Cyrus Jahansouz Paolo Goffredo, MD jogs.org/article/S1091-…


Most viewed this week from JAMA Surgery: This comparative effectiveness research study compares the effectiveness of operative and nonoperative treatment in older adults with multimorbidity who have acute cholecystitis. ja.ma/3SkDXVe



Extended VTE prophylaxis after colorectal surgery for cancer and IBD? Our systematic review suggests low event rates of symptomatic VTE questioning the merits of routine use. Thanks to SSAT for the opportunity to present our work! Lauren Weaver Paolo Goffredo, MD UMN Surgery




Perioperative systemic therapy for resectable colorectal peritoneal metastases #ASCO25 🔎 CAIRO-6 phs 3 trial 👉mPFS 14 vs 7 mo 👉mDFs 12 vs 7 mo 👉mOS 44 vs 39 mo 🧐 No OS benefit in IIT, but better OS in synchronous right-sided tumors ESMO - Eur. Oncology


